Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Advanced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Looking for participantsNCT05532059
What this trial is testing

Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma

Who this might be right for
Advanced Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Ended earlyNCT04203160
What this trial is testing

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Testing effectiveness (Phase 2)UnknownNCT02725073
What this trial is testing

Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma

Who this might be right for
Treatment ResponseAdverse EventsFeasibility
Asan Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00753675
What this trial is testing

Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerGallbladder CancerCancer Of The Extrahepatic Bile Duct+1 more
Genzyme, a Sanofi Company 174
Not applicableUnknownNCT04318834
What this trial is testing

Molecular Profiling of Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre 40
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05039892
What this trial is testing

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma,Adult
3D Medicines (Beijing) Co., Ltd. 50
Testing effectiveness (Phase 2)WithdrawnNCT00386516
What this trial is testing

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Who this might be right for
Cancer of the Bile DuctGallbladder Cancer
Galectin Therapeutics Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07514533
What this trial is testing

The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Sir Run Run Shaw Hospital 60
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Large-scale testing (Phase 3)Ended earlyNCT02082522
What this trial is testing

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Who this might be right for
Hilar Cholangiocarcinoma
Concordia Laboratories Inc. 28
Testing effectiveness (Phase 2)Study completedNCT00059865
What this trial is testing

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 68
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Next Page